Insulin and neurodegenerative disease: shared and specific mechanisms

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994

Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703 · see citing works

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,041 · see citing works

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E., Frosch, M., Eckman, C., Tanzi, R., Selkoe, D., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0230450100 · Cited by 1,361 · see citing works

The Endocrine Regulation of Aging by Insulin-like Signals

Tatar, M., Bartke, A., & Antebi, A. (2003) · Science · doi:10.1126/science.1081447 · Cited by 1,327 · see citing works

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258 · see citing works

Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies

Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207 · see citing works

Insulin receptors are widely distributed in the central nervous system of the rat

Havránková, J., Roth, J., & Brownstein, M. (1978) · Nature · doi:10.1038/272827a0 · Cited by 1,116 · see citing works

Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes

Rulifson, E. J., Kim, S. K., & Nusse, R. (2002) · Science · doi:10.1126/science.1070058 · Cited by 1,064 · see citing works

Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation

Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., & Selkoe, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32730 · Cited by 812 · see citing works

Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748 · see citing works

The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease

Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., & Ashe, K. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01858.2002 · Cited by 714 · see citing works

Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study

Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700 · see citing works

Association of diabetes mellitus and dementia, the Rotterdam study

Ott, A., Stolk, R. P., Hofman, A., van Harskamp, F., Grobbee, D. E., & Breteler, M. M. B. (1996) · Diabetologia · doi:10.1007/s001250050588 · Cited by 677 · see citing works

Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease

Ho, L., Qin, W., Pompl, P., Xiang, Z.-M., Wang, J., Zhao, Z., Peng, Y., Cambareri, G., Rocher, A., Mobbs, C., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0978fje · Cited by 646 · see citing works

Identification of insulin in rat brain.

Havránková, J., Schmechel, D. E., Roth, J., & Brownstein, M. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5737 · Cited by 607 · see citing works

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E genotype

Craft, S., Peskind, E., Schwartz, M. W., Schellenberg, G. D., Raskind, M., & Porte, D. (1998) · Neurology · doi:10.1212/wnl.50.1.164 · Cited by 560 · see citing works

Memory improvement following induced hyperinsulinemia in Alzheimer’s disease

Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., Luby, J., Dagogo-Jack, A., & Alderson, A. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02002-0 · Cited by 538 · see citing works

Brain Insulin Receptors and Spatial Memory

Zhao, W., Chen, H., Xu, H., Moore, E., Meiri, N., Quon, M. J., & Alkon, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34893 · Cited by 535 · see citing works

Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons*

Hong, M., & Lee, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 533 · see citing works

Is Type II Diabetes Associated With an Increased Risk of Cognitive Dysfunction?: A critical review of published studies

Strachan, M. W. J., Deary, I. J., Ewing, F. M. E., & Frier, B. M. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.438 · Cited by 529 · see citing works

Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus

Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527 · see citing works

The role of cerebral ischemia in Alzheimer’s disease

Kalaria, R. N. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00125-1 · Cited by 522 · see citing works

Is Diabetes Associated With Cognitive Impairment and Cognitive Decline Among Older Women?

Gregg, E. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.174 · Cited by 521 · see citing works

Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10q

Bertram, L., Blacker, D., Mullin, K., Keeney, D. B., Jones, J., Basu, S., Yhu, S., McInnis, M. G., Go, R. C. P., Vekrellis, K., et al. (2000) · Science · doi:10.1126/science.290.5500.2302 · Cited by 519 · see citing works

Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved

Pandini, G., Frasca, F., Mineo, R., Sciacca, L., Vigneri, R., & Belfiore, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202766200 · Cited by 499 · see citing works

Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling

Gasparini, L., Gouras, G. K., Wang, R., Gross, R. S., Beal, M. F., Greengard, P., & Xu, H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02561.2001 · Cited by 493 · see citing works

Role of insulin and insulin receptor in learning and memory

Zhao, W., & Alkon, D. L. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00455-5 · Cited by 492 · see citing works

Insulin receptors and insulin action in the brain: review and clinical implications

Schulingkamp, R. J., Pagano, T. C., Hung, D., & Raffa, R. B. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00040-3 · Cited by 491 · see citing works

Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain.

Baura, G. D., Foster, D. M., Porte, D., Kahn, S. E., Bergman, R. N., Cobelli, C., & Schwartz, M. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116773 · Cited by 489 · see citing works

Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation

Schubert, M., Brazil, D. P., Burks, D. J., Kushner, J. A., Ye, J., Flint, C. L., Farhang-Fallah, J., Dikkes, P., Warot, X. M., Rio, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07084.2003 · Cited by 488 · see citing works

Inflammation, autotoxicity and Alzheimer disease

McGeer, P. L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00289-5 · Cited by 474 · see citing works

Serum insulin-like growth factor I regulates brain amyloid-β levels

Carro, E., Trejo, J. L., Gómez‐Isla, T., LeRoith, D., & Torres‐Alemán, I. (2002) · Nature Medicine · doi:10.1038/nm793 · Cited by 448 · see citing works

Serum insulin-like growth factor I regulates brain amyloid-β levels

Carro, E., Jl, T., Gómez‐Isla, T., LeRoith, D., & Torres‐Alemán, I. (2002) · Nature Medicine · doi:10.1038/nm1202-793 · Cited by 442 · see citing works

Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study

Kuusisto, J., Koivisto, K. J., Mykkänen, L. M., Helkala, E.-L., Vanhanen, M., Hänninen, T., Kervinen, K., Kesäniemi, Y. A., Riekkinen, P. J., & Laakso, M. (1997) · BMJ · doi:10.1136/bmj.315.7115.1045 · Cited by 426 · see citing works

Prevalence of Dementia in Older Latinos: The Influence of Type 2 Diabetes Mellitus, Stroke and Genetic Factors

Haan, M. N., Mungas, D. M., Gonzalez, H. M., Ortiz, T. A., Acharya, A., & Jagust, W. J. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51054.x · Cited by 420 · see citing works

Insulin receptors in the central nervous system: Localization, signalling mechanisms and functional aspects

UNGER, J., Livingston, J. H., & Moss, A. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90015-s · Cited by 403 · see citing works

Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

Kurochkin, I. V., & Goto, S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00387-4 · Cited by 401 · see citing works

Susceptibility Locus for Alzheimer's Disease on Chromosome 10

Myers, A., Holmans, P., Marshall, H. N., Kwon, J. M., Meyer, D., Ramic, D., Shears, S., Booth, J., DeVriéze, F. W., Crook, R., et al. (2000) · Science · doi:10.1126/science.290.5500.2304 · Cited by 385 · see citing works

Linkage of Plasma Aβ42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease Pedigrees

Ertekin‐Taner, N., Graff-Radford, N., Younkin, L. H., Eckman, C. B., Baker, M., Adamson, J. L., Ronald, J., Blangero, J., Hutton, M. L., & Younkin, S. G. (2000) · Science · doi:10.1126/science.290.5500.2303 · Cited by 370 · see citing works

NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study

Elias, P. K., Elias, M. F., D'Agostino, R. B., Cupples, L. A., Wilson, P. W., Silbershatz, H., & Wolf, P. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1388 · Cited by 368 · see citing works

Insulin In The Brain

Baskin, D. G., Figlewicz, D. P., Woods, S. C., Porte, D., & Dorsa, D. M. (1987) · Annual Review of Physiology · doi:10.1146/annurev.ph.49.030187.002003 · Cited by 344 · see citing works

Intracerebroventricular insulin enhances memory in a passive-avoidance task

Park, C. R., Seeley, R. J., Craft, S., & WOODS, S. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00220-6 · Cited by 343 · see citing works

Insulin gene expression and insulin synthesis in mammalian neuronal cells.

Devaskar, S. U., Giddings, S. J., Rajakumar, P. A., Carnaghi, L. R., Menon, R. K., & Zahm, D. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37214-9 · Cited by 333 · see citing works

Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 Allele

Cook, D. G., Leverenz, J. B., McMillan, P. J., Kulstad, J. J., Ericksen, S., Roth, R. A., Schellenberg, G. D., Jin, L., Kovacina, K. S., & Craft, S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63822-9 · Cited by 329 · see citing works

The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses

Abbott, M.-A., Wells, D. G., & Fallon, J. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07300.1999 · Cited by 327 · see citing works

Transport of Insulin Across the Blood-Brain Barrier: Saturability at Euglycemic Doses of Insulin

Banks, W. A., Jaspan, J. B., Huang, W., & Kastin, A. J. (1997) · Peptides · doi:10.1016/s0196-9781(97)00231-3 · Cited by 318 · see citing works

Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose

Craft, S., Asthana, S., Newcomer, J. W., Wilkinson, C. W., Matos, I. T., Baker, L. D., Cherrier, M., Lofgreen, C., Latendresse, S., Petrova, A., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1135 · Cited by 312 · see citing works

Improving influence of insulin on cognitive functions in humans

Kern, W., Peters, A., Fruehwald-Schultes, B., Deininger, E., Born, J., & Fehm, H. L. (2001) · Neuroendocrinology · doi:10.1159/000054694 · Cited by 308 · see citing works

Pathophysiological implications of insulin resistance on vascular endothelial function

Wheatcroft, S. B., Williams, I. L., Shah, A. M., & Kearney, M. T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00869.x · Cited by 307 · see citing works

Insulin promotes rapid delivery of N -methyl- d - aspartate receptors to the cell surface by exocytosis

Skeberdis, V. A., Lan, J.-Y., Zheng, X., Zukin, R. S., & Bennett, M. V. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051634698 · Cited by 303 · see citing works

Decreased cognitive function in aging non-insulin-dependent diabetic patients

Perlmuter, L. C., Hakami, M. K., Hodgson-Harrington, C., Ginsberg, J. P., Katz, J., Singer, D. E., & Nathan, D. M. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90186-4 · Cited by 295 · see citing works

The Role of Insulin in Human Brain Glucose Metabolism

Bingham, E., Hopkins, D., Smith, D., Pernet, A., Hallett, W. A., Reed, L. J., Marsden, P. K., & Amiel, S. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3384 · Cited by 293 · see citing works

Insulin resistance and risk for stroke

Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., & Horwitz, R. I. (2002) · Neurology · doi:10.1212/wnl.59.6.809 · Cited by 280 · see citing works

Potential roles of insulin and IGF-1 in Alzheimer's disease

Gasparini, L., & Xu, H. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00163-2 · Cited by 275 · see citing works

Insulin increases CSF Aβ42 levels in normal older adults

Watson, G. S., Peskind, E. R., Asthana, S., Purganan, K., Wait, C., Chapman, D., Schwartz, M. W., Plymate, S. R., & Craft, S. (2003) · Neurology · doi:10.1212/01.wnl.0000065916.25128.25 · Cited by 265 · see citing works

Cerebrospinal Fluid Insulin Levels Increase During Intravenous Insulin Infusions in Man*

Wallum, B. J., Taborsky, G. J., Porte, D., Figlewicz, D. P., Jacobson, L., Beard, J. C., Ward, W. K., & Dorsa, D. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-190 · Cited by 254 · see citing works

Clinical Criteria for the Diagnosis of Vascular Dementia

Chui, H. C., Mack, W. J., Jackson, J. E., Mungas, D., Reed, B. R., Tinklenberg, J. R., Chang, F., Skinner, K., Tasaki, C., & Jagust, W. (2000) · Archives of Neurology · doi:10.1001/archneur.57.2.191 · Cited by 251 · see citing works

The Relationship Between Diabetes Mellitus and Parkinson'S Disease

Sandyk, R. (1993) · International Journal of Neuroscience · doi:10.3109/00207459309003322 · Cited by 244 · see citing works

Degradation of Soluble Amyloid β-Peptides 1–40, 1–42, and the Dutch Variant 1–40Q by Insulin Degrading Enzyme from Alzheimer Disease and Control Brains

Pérez, A., Morelli, L., Cresto, J. C., & Castaño, E. M. (2000) · Neurochemical Research · doi:10.1023/a:1007527721160 · Cited by 240 · see citing works

Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance

Curb, J. D., Rodríguez, B. L., Abbott, R. D., Petrovitch, H., Ross, G. W., Masaki, K., Foley, D. J., Blanchette, P. L., Harris, T. B., Chen, R., et al. (1999) · Neurology · doi:10.1212/wnl.52.5.971 · Cited by 231 · see citing works

The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism

Pressley, J. C., Louis, E. D., Tang, M. ‐., Cote, L. J., Cohen, P. D., Glied, S., & Mayeux, R. P. (2003) · Neurology · doi:10.1212/wnl.60.1.87 · Cited by 229 · see citing works

GLUTX1, a Novel Mammalian Glucose Transporter Expressed in the Central Nervous System and Insulin-sensitive Tissues

Ibberson, M. R., Uldry, M., & Thorens, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4607 · Cited by 228 · see citing works

Selective, Physiological Transport of Insulin Across the Blood-Brain Barrier: Novel Demonstration by Species-Specific Radioimmunoassays

Banks, W. A., Jaspan, J. B., & Kastin, A. J. (1997) · Peptides · doi:10.1016/s0196-9781(97)00198-8 · Cited by 219 · see citing works

Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes.

Hurlbert, M. S., Zhou, W., Wasmeier, C., Kaddis, F. G., Hutton, J. C., & Freed, C. R. (1999) · Diabetes · doi:10.2337/diabetes.48.3.649 · Cited by 218 · see citing works

Insulin and Insulin-Like Growth Factor I Receptors: Similarities and Differences in Signal Transduction

Dupont, J., & LeRoith, D. (2001) · Hormone Research in Paediatrics · doi:10.1159/000063469 · Cited by 217 · see citing works

Insulin-degrading Enzyme Rapidly Removes the β-Amyloid Precursor Protein Intracellular Domain (AICD)

Edbauer, D., Willem, M., Lammich, S., Steiner, H., & Haass, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111571200 · Cited by 214 · see citing works

β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised

Tong, L., Thornton, P. L., Balazs, R., & Cotman, C. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010450200 · Cited by 206 · see citing works

Cognitive Function in an Elderly Population With Persistent Impaired Glucose Tolerance

Vanhanen, M., Koivisto, K. J., Kuusisto, J., Mykkänen, L., Helkala, E., Hänninen, T., Riekkinen, P. J., Soininen, H. S., & Laakso, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.398 · Cited by 185 · see citing works

Degradation of Alzheimer's ß-Amyloid Protein by Human and Rat Brain Peptidases: Involvement of Insulin-Degrading Enzyme

MCDERMOTT, J. R., & GIBSON, A. M. (1997) · Neurochemical Research · doi:10.1023/a:1027325304203 · Cited by 184 · see citing works

Diabetes Mellitus Is a Risk Factor for Vascular Dementia, but Not for Alzheimer’s Disease: A Population-Based Study of the Oldest Old

Hassing, L. B., Johansson, B. E. A., Nilsson, S. E., Berg, S., Pedersen, N. L., Gatz, M., & McClearn, G. E. (2002) · International Psychogeriatrics · doi:10.1017/s104161020200844x · Cited by 175 · see citing works

No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans.

Hasselbalch, S. G., Knudsen, G. M., Videbæk, C. S., Pinborg, L. H., Schmidt, J. F., Holm, S., & Paulson, O. B. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1915 · Cited by 172 · see citing works

Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra

Figlewicz, D. P., Szot, P., Chavez, M., Woods, S. C., & Veith, R. C. (1994) · Brain Research · doi:10.1016/0006-8993(94)91698-5 · Cited by 172 · see citing works

Diabetes mellitus in Huntington disease

Farrer, L. A. (1985) · Clinical Genetics · doi:10.1111/j.1399-0004.1985.tb00185.x · Cited by 170 · see citing works

Insulin-degrading enzyme.

Authier, F., Posner, B. I., & Bergeron, J. J. M. (1996) · PubMed · Cited by 167 · see citing works

Signalling through IGF-I and insulin receptors: where is the specificity?

Kim, J. J., & Accili, D. (2002) · Growth Hormone & IGF Research · doi:10.1054/ghir.2002.0265 · Cited by 163 · see citing works

The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review

Hoyer, S. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200082 · Cited by 161 · see citing works

Vascular Risks and Incident Dementia: Results from a Cohort Study of the Very Old

Brayne, C., Gill, C., Huppert, F. A., Barkley, C., Gehlhaar, E., Girling, D. M., O’Connor, D., & Paykel, E. S. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017043 · Cited by 159 · see citing works

Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender

Craft, S., Asthana, S., Schellenberg, G., Cherrier, M., Baker, L. D., Newcomer, J., Plymate, S., Latendresse, S., Petrova, A., Raskind, M., et al. (1999) · Neuroendocrinology · doi:10.1159/000054469 · Cited by 154 · see citing works

Characterization of risk factors for vascular dementia

Ross, G. W., Petrovitch, H., White, L. R., Masaki, K., Li, C. Y., Curb, J. D., Yano, K., Rodríguez, B. L., Foley, D. J., Blanchette, P. L., et al. (1999) · Neurology · doi:10.1212/wnl.53.2.337 · Cited by 151 · see citing works

Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease

Moroo, I., Yamada, T., Makino, H., Tooyama, I., McGeer, P., Mcgeer, E., & Hirayama, K. (1994) · Acta Neuropathologica · doi:10.1007/bf00313602 · Cited by 149 · see citing works

Immunological Analysis of Glucose Transporters Expressed in Different Regions of the Rat Brain and Central Nervous System

Brant, A. M., Jess, T. J., Milligan, G., Brown, C. M., & Gould, G. W. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1557 · Cited by 145 · see citing works

Vascular parkinsonism: a distinct, heterogeneous clinical entity

Demirkıran, M., Bozdemir, H., & Sarıca, Y. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.104002063.x · Cited by 143 · see citing works

The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome

Baird, T. A., Parsons, M. W., Barber, P. A., Butcher, K., Desmond, P. M., Tress, B. M., Colman, P. G., Jerums, G., Chambers, B. R., & Davis, S. M. (2002) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2002.1081 · Cited by 142 · see citing works

Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study

Jellinger, K. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0676-3 · Cited by 135 · see citing works

Hyperinsulinemia: the missing link among oxidative stress and age-related diseases?

Facchini, F. S., Hua, N. W., Reaven, G. M., & Stoohs, R. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00438-x · Cited by 134 · see citing works

Insulin: new roles for an ancient hormone

Ferrannini, Galvan, Gastaldelli, Camastra, Sironi, Toschi, Baldi, Frascerra, Monzani, Antonelli, et al. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00536.x · Cited by 133 · see citing works

Insulin receptor mRNA in the substantia nigra in Parkinson's disease.

Takahashi, M., Yamada, T., Tooyama, I., Moroo, I., Kimura, H., Yamamoto, T., & Okada, H. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12357-0 · Cited by 131 · see citing works

Huntington's Disease of the Endocrine Pancreas: Insulin Deficiency and Diabetes Mellitus due to Impaired Insulin Gene Expression

Andreassen, O. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0562 · Cited by 123 · see citing works

Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus

Figlewicz, D. P., Szot, P., Israel, P. A., Payne, C., & Dorsa, D. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90258-o · Cited by 121 · see citing works

Essential hypertension and cognitive function. The role of hyperinsulinemia.

Kuusisto, J., Koivisto, K. J., Mykkänen, L. M., Helkala, E.-L., Vanhanen, M., Hänninen, T., Pyörälà, K., Riekkinen, P. J., & Laakso, M. (1993) · Hypertension · doi:10.1161/01.hyp.22.5.771 · Cited by 120 · see citing works

Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans

Soop, M., Duxbury, H., Agwunobi, A. O., Gibson, M., Hopkins, S. J., Childs, C., Cooper, R. G., Maycock, P. F., Little, R. A., & Carlson, G. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00535.2001 · Cited by 118 · see citing works

Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats

Schwartz, M. W., Lattemann, D. F., Kahn, S. E., Baskin, D. G., Greenwood, M. R. C., & Porte, D. (1990) · Peptides · doi:10.1016/0196-9781(90)90044-6 · Cited by 117 · see citing works

Dopamine Receptor Binding Is Increased in Diabetic Rats

Lozovsky, D. B., Saller, C. F., & Kopin, I. J. (1981) · Science · doi:10.1126/science.6458088 · Cited by 117 · see citing works

Effects of Posttraining Administration of Glucose on Retention of a Habituation Response in Mice: Participation of a Central Cholinergic Mechanism

Kopf, S. R., & Baratti, C. M. (1996) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1996.0030 · Cited by 115 · see citing works

Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type

Fujisawa, Y., Sasaki, K., & Akiyama, K. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90158-i · Cited by 113 · see citing works

Aetiological considerations and risk factors for multi-infarct dementia.

Meyer, J. S., McClintic, K., Rogers, R. L., Sims, P., & Mortel, K. F. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.12.1489 · Cited by 108 · see citing works

Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats

Reagan, L. P., Gorovits, N., Hoskin, E. K., Alves, S. E., Katz, E. B., Grillo, C. A., Piroli, G. G., McEwen, B. S., & Charron, M. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051629798 · Cited by 106 · see citing works

Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study

Figlewicz, D. P., Brot, M. D., McCall, A. L., & Szot, P. (1996) · Brain Research · doi:10.1016/0006-8993(96)00727-5 · Cited by 105 · see citing works

F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E

Laight, D. W., Desai, K. M., Gopaul, N. K., Änggård, E., & CARRIER, M. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00407-0 · Cited by 104 · see citing works

Glucose Treatment Reduces Memory Deficits in Young Adult Rats Fed High-Fat Diets

Greenwood, C. E., & Winocur, G. (2001) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2000.3964 · Cited by 97 · see citing works

Expression of colony stimulating factor-1 receptor (CSF-1R) by CNS neurons in mice

Wang, Y., Berezovska, O., & FEDOROFF, S. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990901)57:5 · Cited by 96 · see citing works

Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease

Abraham, R., Myers, A., Wavrant-DeVrièze, F., Hamshere, M. L., Thomas, H. V., Marshall, H. N., Compton, D., Spurlock, G., Turic, D., Hoogendoorn, B., et al. (2001) · Human Genetics · doi:10.1007/s00439-001-0614-1 · Cited by 95 · see citing works

Insulin Synthesis by Isolated Rabbit Neurons*

Schechter, R., Holtzclaw, L. A., Sadiq, F. H., Kahn, A. J., & Devaskar, S. U. (1988) · Endocrinology · doi:10.1210/endo-123-1-505 · Cited by 93 · see citing works

Short-Term and Long-Term Memory in Elderly Patients with NIDDM

Helkala, E., NISKANEN, L. K., Viinamäki, H. T., Partanen, J., & Uusitupa, M. I. J. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.681 · Cited by 92 · see citing works

Abnormal Glucose Tolerance and Arginine Tolerance Tests in Huntington’s Disease

Podolsky, S., & Leopold, N. A. (2009) · Gerontology · doi:10.1159/000212174 · Cited by 90 · see citing works

Intracerebroventricular Administration of Bromocriptine Ameliorates the Insulin-Resistant/Glucose-Intolerant State in Hamsters

Luo, S., Liang, Y. T., & Cincotta, A. H. (1999) · Neuroendocrinology · doi:10.1159/000054415 · Cited by 89 · see citing works

Endothelium, inflammation, and diabetes

Dandona, P. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0019-0 · Cited by 86 · see citing works

Epidemiology of the insulin resistance syndrome

Meigs, J. B. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0057-2 · Cited by 86 · see citing works

Endocrine Function and Glucose Metabolism in Patients with Parkinson's Disease and their Alteration by l -Dopa1

BOYD, A. E., Lebovitz, H. E., & Feldman, J. M. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-5-829 · Cited by 84 · see citing works

Metabolic Responses to Acute and Chronic l -Dopa Administration in Patients with Parkinsonism

Sirtori, C. R., Bolme, P., & Azarnoff, D. L. (1972) · New England Journal of Medicine · doi:10.1056/nejm197210122871501 · Cited by 80 · see citing works

Differential Effects of Proteases Involved in Intracellular Degradation of Amyloid β-Protein between Detergent-Soluble and -Insoluble Pools in CHO-695 Cells

Sudoh, S., Frosch, M. P., & Wolf, B. A. (2002) · Biochemistry · doi:10.1021/bi011193l · Cited by 73 · see citing works

Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes.

Fanelli, C. G., Dence, C. S., Markham, J., Videen, T. O., Paramore, D. S., Cryer, P. E., & Powers, W. J. (1998) · Diabetes · doi:10.2337/diabetes.47.9.1444 · Cited by 69 · see citing works

Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?

Fehm, H. L., Perras, B., Smolnik, R., Kern, W., & Jan Born, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00540-9 · Cited by 69 · see citing works

Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease

Boussaha, M., Hannequin, D., Verpillat, P., Brice, A., Frébourg, T., & Campion, D. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00586-4 · Cited by 68 · see citing works

Glucose intolerance in parkinson's disease

Lipman, I. J., Boykin, M. E., & Flora, R. E. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90031-9 · Cited by 68 · see citing works

PROGRESSION AND PROGNOSIS IN PARKINSONʼS DISEASE

Schwab, R. S. (1960) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196006000-00017 · Cited by 66 · see citing works

Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa

Woert, M. H. V., & Mueller, P. S. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part2360 · Cited by 65 · see citing works

Increased Transcapillary Escape Rate of Albumin in Nondiabetic Men in Response to Hyperinsulinemia

Nestler, J. E., BARLASCINI, C. O., Tetrault, G. A., Fratkin, M. J., Clore, J. N., & Blackard, W. G. (1990) · Diabetes · doi:10.2337/diab.39.10.1212 · Cited by 65 · see citing works

Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE)

Edland, S. D., Vriesé, F. W.-D., Compton, D. M., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Petersen, R. C. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00488-9 · Cited by 64 · see citing works

The Association of Diabetes Mellitus with Dementia in Parkinson's Disease

Sandyk, R., & Awerbuch, G. I. (1992) · International Journal of Neuroscience · doi:10.3109/00207459209000547 · Cited by 63 · see citing works

Effects of Posttraining Administration of Insulin on Retention of a Habituation Response in Mice: Participation of a Central Cholinergic Mechanism

Kopf, S. R., & Baratti, C. M. (1999) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1998.3831 · Cited by 63 · see citing works

Type-2 diabetes and cognitive function in a non-demented population

Vanhanen, M., Kuusisto, J., Koivisto, K. J., Mykkänen, L. M., Helkala, E.-L., Hänninen, T., Riekkinen, P. J., Soininen, H. S., & Laakso, M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb01045.x · Cited by 59 · see citing works

Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study

Levy, G., Tang, M., COTE, L. J., Louis, E. D., Alfaro, B., Mejia‐Santana, H., Stern, Y., & Marder, K. S. (2002) · Movement Disorders · doi:10.1002/mds.10086 · Cited by 57 · see citing works

Effects of Insulin on Local Cerebral Glucose Utilization in the Rat

Lucignani, G., Namba, H., Nehlig, A., Porrino, L. J., Kennedy, C., & Sokoloff, L. (1987) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1987.68 · Cited by 56 · see citing works

Vascular Parkinsonism: A Review of the Precision and Frequency of the Diagnosis

Foltynie, T., Barker, R. A., & Brayne, C. (2001) · Neuroepidemiology · doi:10.1159/000048607 · Cited by 52 · see citing works

Hypothalamic GLUT 4 expression: a glucose- and insulin-sensing mechanism?

Livingstone, C., Lyall, H., & Gould, G. W. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)03423-q · Cited by 52 · see citing works

Insulin, Prostaglandins, and the Pathogenesis of Hypertension

Axelrod, L. (1991) · Diabetes · doi:10.2337/diab.40.10.1223 · Cited by 52 · see citing works

Diabetes decreases limbic extracellular dopamine in rats

Murzi, E., Contreras, Q., Teneus, L., Valecillos, B., Parada, M. A., de Parada, M. P., & Hernandez, L. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12232-x · Cited by 50 · see citing works

Serum levels of coenzyme Q10 in patients with Parkinson's disease

Jiménez‐Jiménez, F. J., Molina, J. A., de Bustos, F., García‐Redondo, A., Gómez-Escalonilla, C., Martínez‐Salio, A., Berbel, Á., Camacho, A., Zurdo, M., Barcenilla, B., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050015 · Cited by 50 · see citing works

Alzheimer Disease and Vascular Dementia: Relationships with Fasting Glucose and Insulin Levels

Carantoni, M., Zuliani, G., Munari, M. R., D’Elia, K., Palmieri, E., & Fellin, R. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017232 · Cited by 47 · see citing works

Four-day hyperinsulinemia in euglycemic conditions alters local cerebral glucose utilization in specific brain nuclei of freely moving rats

Doyle, P., Cusin, I., Rohner‐Jeanrenaud, F., & Jeanrenaud, B. (1995) · Brain Research · doi:10.1016/0006-8993(95)00402-c · Cited by 46 · see citing works

Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease

Liolitsa, D. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.3.261 · Cited by 45 · see citing works

Effects of hyperinsulinemia on local cerebral insulin binding and glucose utilization in normoglycemic awake rats

Marfaing-Jallat, P., Pénicaud, L., Broer, Y., Mraovitch, S., Calando, Y., & Picon, L. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90469-p · Cited by 43 · see citing works

Basal and hyperinsulinemia-induced immunoreactive hypothalamic insulin changes in lean and genetically obese Zucker rats revealed by microdialysis

Gerozissis, K., Orosco, M., Rouch, C., & Nicolaı̈dis, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90511-k · Cited by 40 · see citing works

Bacteriophage T4 Dam DNA-[N6-adenine]Methyltransferase

Evdokimov, A. A., Zinoviev, V. V., Malygin, E. G., Schlagman, S. L., & Hattman, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108864200 · Cited by 38 · see citing works

Confirmation of association between D10S583 and Alzheimer's disease in a case–control sample

Ait‐Ghezala, G., Abdullah, L. I., Crescentini, R. M., Crawford, F., Town, T., Singh, S., Richards, D., Duara, R., & MULLAN, M. J. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00243-4 · Cited by 36 · see citing works

Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines

Singh, B. S., Rajakumar, P. A., Eves, E. M., Rosner, M. R., Wainer, B. H., & Devaskar, S. U. (1997) · Regulatory Peptides · doi:10.1016/s0167-0115(96)02120-9 · Cited by 30 · see citing works

Risk factors for dementia in Parkinson's disease.

Salganik, I., & Korczyn, A. D. (1990) · PubMed · Cited by 30 · see citing works

Peptide derived from insulin with regulatory activity of dopamine transporter

Liu, Z., Wang, Y., Zhao, W., Ding, J., Mei, Z.-T., Guo, L., Cui, D., & Fei, J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00092-2 · Cited by 24 · see citing works

Altered conditioned taste aversion and glucose utilization in related brain nuclei of diabetic GK rats

Marfaing-Jallat, P., Portha, B., & Pénicaud, L. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00060-r · Cited by 18 · see citing works

Insulin receptor substrate protein p53 localization in rats suggests mechanism for specific polyglutamine neurodegeneration

Thomas, E. A., Foye, P. E., Alvarez, C. E., Usui, H., & Sutcliffe, J. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02064-x · Cited by 17 · see citing works

Normal cerebrospinal fluid levels of insulin in patients with Parkinson's disease

Jiménez‐Jiménez, F. J., Molina, J. A., Vargas, C., Gómez, P. A., de Bustos, F., Zurdo, M., Gómez-Escalonilla, C., Barcenilla, B., Berbel, Á., Camacho, A., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070086 · Cited by 14 · see citing works

Untitled work

(1998) · doi:10.1002/(sici)1096-9861(19981005)399:4

Risk of dementia in diabetes mellitus: a systematic review

Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · see citing works

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128 · see citing works

Intranasal insulin improves cognition and modulates β-amyloid in early AD

Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830 · see citing works

Cognition and diabetes: a lifespan perspective

Biessels, G. J., Deary, I. J., & Ryan, C. M. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70021-8 · Cited by 646 · see citing works

Is Alzheimer’s disease a type 3 diabetes? A critical appraisal

Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621 · see citing works

Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype

Reger, M. A., Watson, G. S., Frey, W. H., Baker, L. D., Cholerton, B., Keeling, M. L., Belongia, D., Fishel, M. A., Plymate, S. R., Schellenberg, G. D., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.016 · Cited by 619 · see citing works

Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone

Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Fishel, M. A., Kulstad, J. J., Green, P. S., Cook, D. G., et al. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 607 · see citing works

Amyloid beta oligomers induce impairment of neuronal insulin receptors

Zhao, W., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2008) · The FASEB Journal · doi:10.1096/fj.06-7703com · Cited by 587 · see citing works

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

Li, Y., Perry, T., Kindy, M. S., Harvey, B. K., Tweedie, D., Holloway, H. W., Powers, K., Shen, H., Egan, J. M., Sambamurti, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806720106 · Cited by 589 · see citing works

The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia: Two Roads Converged

Craft, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.27 · Cited by 547 · see citing works

Brain abnormalities in human obesity: A voxel-based morphometric study

Pannacciulli, N., Del Parigi, A., Chen, K., Le, D. S. N. T., Reiman, E. M., & Tataranni, P. A. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.047 · Cited by 523 · see citing works

Insulin Resistance and Alzheimers Disease Pathogenesis: Potential Mechanisms and Implications for Treatment

Craft, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362137 · Cited by 487 · see citing works

Type 2 Diabetes and the Risk of Parkinson's Disease

Hu, G., Jousilahti, P., Bidel, S., Antikainen, R., & Tuomilehto, J. (2007) · Diabetes Care · doi:10.2337/dc06-2011 · Cited by 466 · see citing works

Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia

Claxton, A., Baker, L. D., Hanson, A., Trittschuh, E. H., Cholerton, B., Morgan, A., Callaghan, M., Arbuckle, M., Behl, C., & Craft, S. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141791 · Cited by 467 · see citing works

Insulin signaling in the central nervous system: Learning to survive

van der Heide, L. P., Ramakers, G. M. J., & Smidt, M. P. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.06.003 · Cited by 444 · see citing works

Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes Amyloidogenesis

O’Connor, T., Sadleir, K. R., Maus, E., Velliquette, R. A., Zhao, J., Cole, S. L., Eimer, W. A., Hitt, B. D., Bembinster, L. A., Lammich, S., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.047 · Cited by 422 · see citing works

Biological mechanisms underlying the role of physical fitness in health and resilience

Silverman, M. N., & Deuster, P. A. (2014) · Interface Focus · doi:10.1098/rsfs.2014.0040 · Cited by 416 · see citing works

Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain

Butterfield, D. A., Di Domenico, F., & Barone, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.010 · Cited by 402 · see citing works

Risk factors for progression of brain atrophy in aging

Enzinger, C., Fazekas, F., Matthews, P. M., Ropele, S., Schmidt, H., Smith, S. M., & Schmidt, R. (2005) · Neurology · doi:10.1212/01.wnl.0000161871.83614.bb · Cited by 397 · see citing works

Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance

McNay, E. C., Ong, C. T., McCrimmon, R. J., Cresswell, J. A., Bogan, J. S., & Sherwin, R. S. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.02.002 · Cited by 398 · see citing works

Antidiabetic drug metformin (Glucophage ^R ) increases biogenesis of Alzheimer's amyloid peptides via up-regulating <i>BACE1</i> transcription

Chen, Y., Zhou, K., Wang, R., Liu, Y., Kwak, Y.-D., Ma, T., Thompson, R. C., Zhao, Y., Smith, L., Gasparini, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807991106 · Cited by 390 · see citing works

Overweight Is Associated With Decreased Cognitive Functioning Among School‐age Children and Adolescents

Li, Y., Dai, Q., Jackson, J. C., & Zhang, J. (2008) · Obesity · doi:10.1038/oby.2008.296 · Cited by 387 · see citing works

(Pre)diabetes, brain aging, and cognition

Roriz‐Filho, J. S., Roriz, T. M. D. S., Rosset, I., Camozzato, A. L., dos Santos, A. C., Chaves, M. L. F., Moriguti, J. C., & Roriz‐Cruz, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.12.003 · Cited by 390 · see citing works

Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease

Sato, T., Hanyu, H., Hirao, K., Kanetaka, H., Sakurai, H., & Iwamoto, T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.009 · Cited by 387 · see citing works

Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation

Craft, S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.021 · Cited by 347 · see citing works

Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease

Kapogiannis, D., Boxer, A. L., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U. B., Frassetto, L. A., Petersen, R. C., Miller, B. L., & Goetzl, E. J. (2014) · The FASEB Journal · doi:10.1096/fj.14-262048 · Cited by 345 · see citing works

A life-course approach to the aetiology of late-onset dementias

Whalley, L. J., Dick, F. D., & McNeill, G. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70286-6 · Cited by 346 · see citing works

Amylin deposition in the brain: A second amyloid in Alzheimer disease?

Jackson, K., Barisone, G. A., Dı́az, E., Jin, L., DeCarli, C. S., & Despa, F. (2013) · Annals of Neurology · doi:10.1002/ana.23956 · Cited by 340 · see citing works

Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease

Cao, D., Lu, H., Lewis, T. L., & Li, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703561200 · Cited by 336 · see citing works

Insulin Signaling in the Central Nervous System

Porte, D., Baskin, D. G., & Schwartz, M. W. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1264 · Cited by 334 · see citing works

Alzheimer’s disease and insulin resistance: translating basic science into clinical applications

Felice, F. G. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64595 · Cited by 328 · see citing works

High-fat diets, insulin resistance and declining cognitive function

Greenwood, C. E., & Winocur, G. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.017 · Cited by 330 · see citing works

Insulin in Central Nervous System: More than Just a Peripheral Hormone

Duarte, A. I., Moreira, P. I., & Oliveira, C. R. (2012) · Journal of Aging Research · doi:10.1155/2012/384017 · Cited by 324 · see citing works

Type 2 diabetes mellitus and Alzheimer’s disease

Barbagallo, M. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.889 · Cited by 313 · see citing works

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?

Bassil, F., Fernagut, P., Bézard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 313 · see citing works

Impairment of the glymphatic system after diabetes

Jiang, Q., Zhang, L., Ding, G., Davoodi-Bojd, E., Li, Q., Li, L., Sadry, N., Nedergaard, M., Chopp, M., & Zhang, Z. (2017) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1177/0271678x16654702 · Cited by 308 · see citing works

The Therapeutic Potential of Metformin in Neurodegenerative Diseases

Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 310 · see citing works

Metabolic Dysfunction in Alzheimers Disease and Related Neurodegenerative Disorders

Cai, H., Cong, W., Ji, S., Rothman, S. M., Maudsley, S. R., & Martin, B. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015064 · Cited by 308 · see citing works

Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives

Béard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 309 · see citing works

Intranasal Insulin Improves Memory in Humans: Superiority of Insulin Aspart

Benedict, C., Hallschmid, M., Schmitz, K., Schultes, B., Ratter, F., Fehm, H. L., Born, J., & Kern, W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301193 · Cited by 302 · see citing works

K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons

Liss, B., Haeckel, O., Wildmann, J., Miki, T., Seino, S., & Roeper, J. (2005) · Nature Neuroscience · doi:10.1038/nn1570 · Cited by 300 · see citing works

Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes

Zhao, N., Liu, C.-C., Van Ingelgom, A. J., Martens, Y. A., Linares, C., Knight, J. A., Painter, M. M., Sullivan, P. M., & Bu, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.003 · Cited by 289 · see citing works

Association of metabolic syndrome with Alzheimer disease

Vanhanen, M., Koivisto, K. J., Moilanen, L., Helkala, E.-L., Hänninen, T., Soininen, H. S., Kervinen, K., Kesäniemi, Y. A., Laakso, M., & Kuusisto, J. (2006) · Neurology · doi:10.1212/01.wnl.0000234037.91185.99 · Cited by 295 · see citing works

Aberrant insulin signaling in Alzheimer's disease: current knowledge

Bedse, G., Domenico, F. D., Serviddio, G., & Cassano, T. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00204 · Cited by 294 · see citing works

2003-2013: A Decade of Body Mass Index, Alzheimer's Disease, and Dementia

Emmerzaal, T. L., Kiliaan, A. J., & Gustafson, D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141086 · Cited by 295 · see citing works

Therapy insight, type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease

Haan, M. N. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0124 · Cited by 284 · see citing works

Parkinson's disease, insulin resistance and novel agents of neuroprotection

Avilés-Olmos, I., Limousin, P. D., Lees, A. J., & Foltynie, T. (2012) · Brain · doi:10.1093/brain/aws009 · Cited by 284 · see citing works

Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?

McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653377 · Cited by 277 · see citing works

Memory impairment in obese Zucker rats: An investigation of cognitive function in an animal model of insulin resistance and obesity.

Winocur, G., Greenwood, C. E., Piroli, G. G., Grillo, C. A., Reznikov, L. R., Reagan, L. P., & McEwen, B. S. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.5.1389 · Cited by 281 · see citing works

Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages

Neth, B. J., & Craft, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00345 · Cited by 275 · see citing works

Diabetes Mellitus and the Risk of Alzheimer’s Disease: A Nationwide Population-Based Study

Huang, C., Chung, C., Leu, H., Lin, L., Chiu, C.-C., Hsu, C., Chiang, C.-H., Huang, P., Chen, T., Lin, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087095 · Cited by 266 · see citing works

Insulin resistance predicts brain amyloid deposition in late middle‐aged adults

Willette, A. A., Johnson, S. C., Birdsill, A. C., Sager, M. A., Christian, B., Baker, L. D., Craft, S., Oh, J. M., Statz, E. H., Hermann, B. P., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.03.011 · Cited by 261 · see citing works

Cognitive remission: a novel objective for the treatment of major depression?

Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252 · see citing works

Cognitive dysfunction in patients with type 2 diabetes

Reijmer, Y. D., van den Berg, E., Ruis, C., Kappelle, L. J., & Biessels, G. J. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1112 · Cited by 251 · see citing works

Amyloid-β as a Modulator of Synaptic Plasticity

Parihar, M. S., & Brewer, G. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101020 · Cited by 249 · see citing works

Diabetes and Risk of Parkinson’s Disease

Cereda, E., Barichella, M., Pedrolli, C., Klersy, C., Cassani, E., Caccialanza, R., & Pezzoli, G. (2011) · Diabetes Care · doi:10.2337/dc11-1584 · Cited by 247 · see citing works

The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?

Kroner, Z. (2009) · PubMed · Cited by 246 · see citing works

Diabetes mellitus and Parkinson disease

Pagano, G., Polychronis, S., Wilson, H., Giordano, B., Ferrara, N., Niccolini, F., & Politis, M. (2018) · Neurology · doi:10.1212/wnl.0000000000005475 · Cited by 243 · see citing works

High-Fat Diet Induces Hepatic Insulin Resistance and Impairment of Synaptic Plasticity

Liu, Z., Patil, I., Jiang, T., Sancheti, H., Walsh, J. P., Stiles, B. L., Yin, F., & Cadenas, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128274 · Cited by 236 · see citing works

The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease

Cheong, J. L. Y., Pablo‐Fernández, E. D., Foltynie, T., & Noyce, A. J. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191900 · Cited by 230 · see citing works

Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes

McNay, E. C., & Recknagel, A. K. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.005 · Cited by 229 · see citing works

Insulin, cognition, and dementia

Cholerton, B., Baker, L. D., & Craft, S. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.08.008 · Cited by 229 · see citing works

Incident dementia in women is preceded by weight loss by at least a decade

Knopman, D. S., Edland, S. D., Cha, R. H., Petersen, R. C., & Rocca, W. A. (2007) · Neurology · doi:10.1212/01.wnl.0000267661.65586.33 · Cited by 226 · see citing works

‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue

Pérez, L. M., Pareja‐Galeano, H., Sanchis‐Gomar, F., Emanuele, E., Lucia, A., & Gálvez, B. G. (2016) · The Journal of Physiology · doi:10.1113/jp271691 · Cited by 215 · see citing works

Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults

Willette, A. A., Xu, G., Johnson, S. C., Birdsill, A. C., Jonaitis, E. M., Sager, M. A., Hermann, B. P., Rue, A. L., Asthana, S., & Bendlin, B. B. (2012) · Diabetes Care · doi:10.2337/dc12-0922 · Cited by 225 · see citing works

The genetic landscape of Parkinson's disease

Lunati, A., Lesage, S., & Brice, A. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.08.004 · Cited by 218 · see citing works

Diabetes Mellitus and Dementia

Ninomiya, T. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0487-z · Cited by 211 · see citing works

Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects

Jl, T., Piriz, J., Llorens-Martı́n, M., Fernandez, A. M., Bolós, M., LeRoith, D., Núñez, Á., & Torres‐Alemán, I. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002076 · Cited by 210 · see citing works

Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies

Yarchoan, M. M., Toledo, J. B., Lee, E. B., Arvanitakis, Z., Kazi, H., Han, L.-Y., Louneva, N., Lee, V. M. ‐., Kim, S. F., Trojanowski, J. Q., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1328-5 · Cited by 206 · see citing works

A biochemical and functional characterization of diet‐induced brain insulin resistance

Mielke, J. G., Taghibiglou, C., Liu, L., Zhang, Y., Jia, Z., Adeli, K., & Wang, Y. T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03155.x · Cited by 205 · see citing works

The Insulin/Akt Signaling Pathway Is Targeted by Intracellular β-Amyloid

Lee, H., Kumar, P., Fu, Q., Rosen, K. M., & Querfurth, H. W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0777 · Cited by 205 · see citing works

The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms

McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., & Kennedy, S. H. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.1.157 · Cited by 200 · see citing works

Type 2 Diabetes and Cognitive Impairment: Linking Mechanisms

Luchsinger, J. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111433 · Cited by 196 · see citing works

Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes

Manschot, S., Biessels, G. J., de Valk, H. W., Algra, A., Rutten, G. E. H. M., van der Grond, J., Kappelle, L. J., & on behalf of the Utrecht Diabetic Encephalopathy Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0792-z · Cited by 198 · see citing works

Type 2 diabetes and risk of cognitive impairment and dementia

Whitmer, R. A. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0058-7 · Cited by 195 · see citing works

Risk of Parkinson Disease in Diabetes Mellitus

Yue, X., Li, H., Yan, H., Zhang, P., Li, C., & Li, T. (2016) · Medicine · doi:10.1097/md.0000000000003549 · Cited by 188 · see citing works

<scp>DPP</scp>4‐inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high‐fat diet consumption

Pipatpiboon, N., Pintana, H., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12088 · Cited by 183 · see citing works

Risk of Parkinson Disease Onset in Patients With Diabetes

Sun, Y., Chang, Y., Chen, H.-F., Su, Y., Su, H.-F., & Li, C. (2012) · Diabetes Care · doi:10.2337/dc11-1511 · Cited by 185 · see citing works

Diabetes and Insulin in Regulation of Brain Cholesterol Metabolism

Suzuki, R., Lee, K., Jing, E., Biddinger, S. B., McDonald, J. G., Montine, T. J., Craft, S., & Kahn, C. R. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.006 · Cited by 183 · see citing works

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

McCutchan, J. A., Marquie‐Beck, J., Fitzsimons, C., Letendre, S. L., Ellis, R. J., Heaton, R. K., Wolfson, T. J., Rosario, D., Alexander, T. J., Marra, C. M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182478d64 · Cited by 179 · see citing works

Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease

Rasgon, N., Kenna, H. A., Wroolie, T., Kelley, R. G., Silverman, D. H. S., Brooks, J. O., Williams, K. E., Powers, B. N., Hallmayer, J. F., & Reiss, A. L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.005 · Cited by 180 · see citing works

Inside the Diabetic Brain: Role of Different Players Involved in Cognitive Decline

Gaspar, J. M., Baptista, F. I., Macedo, M. P., & Ambrósio, A. F. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00240 · Cited by 179 · see citing works

Intranasal Insulin for Alzheimer’s Disease

Hallschmid, M. (2021) · CNS Drugs · doi:10.1007/s40263-020-00781-x · Cited by 182 · see citing works

Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson Disease

Lautier, C., Goldwurm, S., Dürr, A., Giovannone, B., Tsiaras, W. G., Pezzoli, G., Brice, A., & Smith, R. J. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.015 · Cited by 177 · see citing works

Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study

Noyce, A. J., Kia, D. A., Hemani, G., Nicolas, A., Price, T. R., Pablo‐Fernández, E. D., Haycock, P., Lewis, P. A., Foltynie, T., Smith, G. D., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002314 · Cited by 175 · see citing works

A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease

Geldmacher, D. S., Fritsch, T., McClendon, M. J., & Landreth, G. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.229 · Cited by 221 · see citing works

Insulin Resistance Syndrome and Alzheimer Disease: Pathophysiologic Mechanisms and Therapeutic Implications

Craft, S. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213866.86934.7e · Cited by 167 · see citing works

Clinical features of Parkinson disease when onset of diabetes came first

Cereda, E., Barichella, M., Cassani, E., Caccialanza, R., & Pezzoli, G. (2012) · Neurology · doi:10.1212/wnl.0b013e3182553cc9 · Cited by 166 · see citing works

Obesity, diabetes, and risk of Parkinson's disease

Palacios, N., Gao, X., McCullough, M. L., Jacobs, E. J., Patel, A. V., Mayo, T. L., Schwarzschild, M. A., & Ascherio, A. (2011) · Movement Disorders · doi:10.1002/mds.23855 · Cited by 165 · see citing works

Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus

Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Liauw, S. S. L., Alsuwaidan, M. T., Yim, C. Y., & McIntyre, R. S. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8140-8 · Cited by 162 · see citing works

Does the brain shrink as the waist expands?

Willette, A. A., & Kapogiannis, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.03.007 · Cited by 162 · see citing works

Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms

Panza, F., Frisardi, V., Capurso, C. A., Imbimbo, B. P., Vendemiale, G., Santamato, A., D’Onofrio, G., Seripa, D., Sancarlo, D., Pilotto, A., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091669 · Cited by 162 · see citing works

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets

Hamzé, R., Delangre, E., Tolu, S., Moreau, M., Janel, N., Bailbé, D., & Movassat, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315287 · Cited by 163 · see citing works

Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology

Beeri, M. S., Schmeidler, J., Silverman, J. M., Gandy, S., Wysocki, M., Hannigan, C. M., Purohit, D. P., Lesser, G., Grossman, H. T., & Haroutunian, V. (2008) · Neurology · doi:10.1212/01.wnl.0000324925.95210.6d · Cited by 157 · see citing works

Insulin resistance and outcome in bipolar disorder

Calkin, C. V., Růžičková, M., Uher, R., Hájek, T., Slaney, C., Garnham, J. S., O’Donovan, M. C., & Alda, M. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.152850 · Cited by 158 · see citing works

Metabolome in schizophrenia and other psychotic disorders: a general population-based study

Orešič, M., Tang, J. P., Seppänen‐Laakso, T., Mattila, I. M., Saarni, S. E., Saarni, S. I., Lönnqvist, J. K., Sysi‐Aho, M., Hyötyläinen, T., Perälä, J., et al. (2011) · Genome Medicine · doi:10.1186/gm233 · Cited by 158 · see citing works

Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link

Korczak, D. J., Pereira, S., Koulajian, K., Matejcek, A., & Giacca, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2240-3 · Cited by 160 · see citing works

Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease

Pasinetti, G. M., & Eberstein, J. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05454.x · Cited by 157 · see citing works

Metabolic Syndrome and Cognitive Function: A Population-Based Follow-Up Study in Elderly Women

Komulainen, P., Lakka, T. A., Kivipelto, M., Hassinen, M., Helkala, E., Haapala, I., Nissinen, A. M., & Rauramaa, R. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000096636 · Cited by 156 · see citing works

Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders

Ghasemi, R., Dargahi, L., Haeri, A., Moosavi, M., Mohamed, Z., & Ahmadiani, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8404-z · Cited by 121 · see citing works

Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches

Kellar, D., & Craft, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30231-3 · Cited by 832 · see citing works

Mechanisms of action of brain insulin against neurodegenerative diseases

Ramalingam, M., & Kim, S. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1147-1 · Cited by 29 · see citing works

Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?

Blum-Degen, D., Frölich, L., Hoyer, S., & Riederer, P. F. (1995) · PubMed · Cited by 55 · see citing works

Role of Insulin in Brain: An Emphasis on Molecular Functions

Kundu, S., & Firdous, S. M. (2022) · INNOSC Theranostics and Pharmacological Sciences · doi:10.36922/itps.v4i2.43 · Cited by 1 · see citing works